OpenLB
Open Library of Bioscience
Advanced Search
International journal of environmental research and public health
09 22, 2022;19 (19):

A Clinical Preventive Strategy Based on a Digital Tool to Improve Access to Endocrine Disruptors Exposure Prevention: The MEDPREVED Study.

Marion Albouy, Maud Parthenay, Maeva Nogues, Agathe Leyris, Léa Degorce, Zacharie Barthelemy, Diana Rafidison, Anne-Sophie Gourgues, Virginie Migeot, Jean Pylouster, Antoine Dupuis
Author Information
  1. Marion Albouy: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  2. Maud Parthenay: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France. ORCID
  3. Maeva Nogues: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  4. Agathe Leyris: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  5. Léa Degorce: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  6. Zacharie Barthelemy: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  7. Diana Rafidison: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  8. Anne-Sophie Gourgues: BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France.
  9. Virginie Migeot: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France.
  10. Jean Pylouster: Research Centre on Cognition and Learning, MSHS, 5 Rue T. Lefebvre, CEDEX, 86073 Poitiers, France.
  11. Antoine Dupuis: Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France. ORCID
PMID: 36231296 DOI: 10.3390/ijerph191911993

Abstract

: The digitalized PREVED (PREgnancy, PreVention, Endocrine Disruptor) questionnaire was used in the clinical practices of health professionals (HP) who adhered to the MEDPREVED strategy. The objectives were to assess the strategy and to determine if it could improve access to endocrine disruptor (ED) exposure prevention. : After having filled in the digital questionnaire in HP waiting rooms, patients were invited to talk about ED exposure during the consultation. HPs were previously trained in ED and had received a prevention kit for their patients. After the seven-month implementation phase, the evaluation phase consisted of five mixed assessments: interviews with: (i) patients who were young children's parents; (ii) patients in the general population; (iii) paediatricians; (iv) midwives; and a quantitative study on GPs. Assessment concerned feasibility, accessibility, and usefulness of the strategy; we then used the Levesque model to evaluate how it could improve access to ED exposure prevention. : The study included 69 participants. The strategy appeared feasible for the filling-out step due to digital and environment access. However, it depended on patient and HP profiles. The strategy seemed useful insofar as it facilitated reflexive investment, an intention to healthy behaviour and, rather rarely, talk about ED exposure. The beginning of this discussion depended on time, prioritizing of the topic and HP profile. The strategy has confirmed the Levesque model's limiting factors and levers to access ED prevention. : The MEDPREVED strategy is feasible, accessible, and useful in clinical prevention practice. Further study is needed to measure the impact on knowledge, risk perception and behavior of beneficiaries of the MEDPREVED strategy in the medium and long term.

Keywords

clinical prevention endocrine disruptor environmental health general practitioners health education health professionals midwives paediatricians

References

  1. BMJ Open. 2017 Nov 8;7(10):e017902 [PMID: 29118053]
  2. Patient Educ Couns. 2014 Feb;94(2):149-57 [PMID: 24207115]
  3. Clin Pediatr (Phila). 2019 Jan;58(1):73-78 [PMID: 30338699]
  4. Am J Clin Nutr. 2011 Dec;94(6 Suppl):1754S-1758S [PMID: 21525196]
  5. Front Med (Lausanne). 2015 May 18;2:32 [PMID: 26042219]
  6. Int J Environ Res Public Health. 2020 Mar 24;17(6): [PMID: 32213890]
  7. Cyberpsychol Behav Soc Netw. 2020 Jun;23(6):363-370 [PMID: 32271619]
  8. PLoS One. 2020 Mar 30;15(3):e0230828 [PMID: 32226031]
  9. Environ Health Perspect. 2011 Jul;119(7):914-20 [PMID: 21450549]
  10. JAMA. 2011 Nov 23;306(20):2218-20 [PMID: 22110104]
  11. Soc Sci Med. 2000 Mar;50(6):813-28 [PMID: 10695979]
  12. BMC Res Notes. 2012 Sep 18;5:511 [PMID: 22988947]
  13. Br J Gen Pract. 1994 Dec;44(389):583-5 [PMID: 7748670]
  14. Tex Med. 2005 Oct;101(10):62-70 [PMID: 17094519]
  15. BMC Med Educ. 2021 Jan 8;21(1):40 [PMID: 33419439]
  16. BMC Med Inform Decis Mak. 2016 Nov 3;16(1):138 [PMID: 27809908]
  17. BMC Pregnancy Childbirth. 2015 Nov 25;15:312 [PMID: 26608131]
  18. Int J Gynaecol Obstet. 2015 Dec;131(3):219-25 [PMID: 26433469]
  19. BMC Public Health. 2021 Jan 14;21(1):134 [PMID: 33446158]
  20. Addiction. 2007 Nov;102(11):1762-70 [PMID: 17784901]
  21. Int J Environ Res Public Health. 2018 Oct 15;15(10): [PMID: 30326668]
  22. J Med Syst. 2014 Jan;38(1):9995 [PMID: 24346929]
  23. J Med Internet Res. 2016 Oct 04;18(10):e264 [PMID: 27702738]
  24. Health Promot Pract. 2016 Sep;17(5):731-8 [PMID: 27091608]
  25. Lancet. 1991 Oct 26;338(8774):1059-63 [PMID: 1681366]
  26. Paediatr Child Health. 2006 Apr;11(4):235-8 [PMID: 19030279]
  27. BMC Med Inform Decis Mak. 2020 Oct 6;20(1):253 [PMID: 33023577]
  28. Can J Public Health. 2008 Jan-Feb;99(1):31-5 [PMID: 18435387]
  29. BJGP Open. 2018 Sep 19;2(3):bjgpopen18X101607 [PMID: 30564740]
  30. Int J Environ Res Public Health. 2016 Dec 18;13(12): [PMID: 27999342]
  31. J Expo Sci Environ Epidemiol. 2013 Jul;23(4):378-84 [PMID: 23443238]
  32. Soc Sci Med. 1989;29(1):35-42 [PMID: 2740926]
  33. Ann Biol Clin (Paris). 2017 Dec 1;75(6):673-681 [PMID: 29192600]
  34. Food Chem Toxicol. 2013 May;55:8-17 [PMID: 23174517]
  35. Ann Behav Med. 2013 Aug;46(1):81-95 [PMID: 23512568]
  36. PLoS One. 2021 Mar 17;16(3):e0247909 [PMID: 33730057]
  37. Breastfeed Med. 2014 Apr;9(3):135-41 [PMID: 24283957]
  38. Rev Mal Respir. 2006 Nov;23(5 Pt 1):426-9 [PMID: 17314741]
  39. Glob Health Action. 2015 Jun 24;8:27106 [PMID: 26112142]
  40. J Emerg Med. 2012 Jul;43(1):172-81 [PMID: 22325555]
  41. J Altern Complement Med. 2012 Apr;18(4):309-10 [PMID: 22489774]
  42. Health Educ Q. 1985 Spring;12(1):35-50 [PMID: 3980239]
  43. Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148 [PMID: 29476653]
  44. Inform Health Soc Care. 2020 Jan;45(1):15-30 [PMID: 30479185]
  45. Int J Med Inform. 2021 Apr;148:104376 [PMID: 33453635]
  46. Public Health. 2005 Nov;119(11):981-6 [PMID: 16185735]
  47. Int J Public Health. 2019 Jun;64(5):679-690 [PMID: 30758514]
  48. Br Dent J. 2003 Jun 28;194(12):683-8; discussion 675 [PMID: 12830193]
  49. JAMA Dermatol. 2018 Sep 1;154(9):1085-1086 [PMID: 30046805]
  50. Int J Environ Res Public Health. 2019 Jul 16;16(14): [PMID: 31315307]
  51. Am J Prev Med. 2011 Oct;41(4 Suppl 3):S296-301 [PMID: 21961679]
  52. Can Fam Physician. 2019 Jun;65(6):e269-e277 [PMID: 31189641]
  53. BMC Fam Pract. 2011 Sep 28;12:104 [PMID: 21955570]
  54. Sex Transm Dis. 2020 Feb;47(2):130-135 [PMID: 31834206]
  55. J Gen Intern Med. 2013 Nov;28(11):1504-10 [PMID: 23576243]
  56. AIDS Behav. 2019 Jan;23(1):272-282 [PMID: 30008051]
  57. Aust J Gen Pract. 2018 Dec;47(12):870-875 [PMID: 31212407]
  58. J Cardiovasc Nurs. 2013 Jul-Aug;28(4):320-9 [PMID: 22635061]
  59. Arch Pediatr. 2005 Jan;12(1):10-5 [PMID: 15653048]
  60. Curr Opin Psychol. 2015 Oct 1;5:85-89 [PMID: 26258160]
  61. Environ Health. 2012 Jun 27;11:42 [PMID: 22715989]
  62. Patient Educ Couns. 2007 Apr;66(1):13-20 [PMID: 17084059]
  63. Trials. 2021 Dec 4;22(1):876 [PMID: 34863252]
  64. WMJ. 2006 Mar;105(2):45-9 [PMID: 16628975]
  65. Environ Sci Pollut Res Int. 2020 Jan;27(3):3247-3256 [PMID: 31838679]
  66. J Altern Complement Med. 2012 Apr;18(4):329-33 [PMID: 22489806]
  67. JMIR Mhealth Uhealth. 2021 Mar 23;9(3):e21128 [PMID: 33755025]
  68. Int J Environ Res Public Health. 2021 Dec 22;19(1): [PMID: 35010328]
  69. Int J Equity Health. 2013 Mar 11;12:18 [PMID: 23496984]
  70. J Educ Health Promot. 2020 Sep 28;9:241 [PMID: 33209933]
  71. Can J Public Health. 2010 Jan-Feb;101(1):65-71 [PMID: 20364542]
  72. J Pediatr Health Care. 2006 May-Jun;20(3):192-7 [PMID: 16675380]
  73. Rev Med Suisse. 2006 Sep 27;2(80):2163-4, 2166-8 [PMID: 17063647]
  74. J Epidemiol Community Health. 2020 Aug;74(8):617-619 [PMID: 32385125]
  75. Alcohol Res Health. 1999;23(2):128-37 [PMID: 10890807]
  76. Rev Med Suisse. 2016 Nov 30;12(541):2084-2086 [PMID: 28700154]
  77. Cochrane Database Syst Rev. 2013 May 31;(5):CD000165 [PMID: 23728631]
  78. Health Promot Int. 2008 Sep;23(3):240-50 [PMID: 18397953]
  79. Mayo Clin Proc. 2015 Apr;90(4):469-80 [PMID: 25841251]
  80. Acad Pediatr. 2009 Mar-Apr;9(2):129-30 [PMID: 19329105]
  81. Adv Exp Med Biol. 2019;1211:1-16 [PMID: 31273574]

MeSH Term

Attitude of Health Personnel
Child
Child, Preschool
Endocrine Disruptors
Female
Health Personnel
Humans
Midwifery
Pregnancy
Surveys and Questionnaires

Chemicals

Endocrine Disruptors
Journal Article Research Support, Non-U.S. Gov't
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0strategyEDprevention:healthHPMEDPREVEDaccessexposurepatientsclinicalstudyEndocrinequestionnaireusedprofessionalsimproveendocrinedisruptordigitaltalkphasegeneralpaediatriciansmidwivesLevesquefeasibledependedusefuldigitalizedPREVEDPREgnancyPreVentionDisruptorpracticesadheredobjectivesassessdeterminefilledwaitingroomsinvitedconsultationHPspreviouslytrainedreceivedkitseven-monthimplementationevaluationconsistedfivemixedassessments:interviewswith:youngchildren'sparentsiipopulationiiiivquantitativeGPsAssessmentconcernedfeasibilityaccessibilityusefulnessmodelevaluateincluded69participantsappearedfilling-outstepdueenvironmentHoweverpatientprofilesseemedinsofarfacilitatedreflexiveinvestmentintentionhealthybehaviourratherrarelybeginningdiscussiontimeprioritizingtopicprofileconfirmedmodel'slimitingfactorsleversaccessiblepracticeneededmeasureimpactknowledgeriskperceptionbehaviorbeneficiariesmediumlongtermClinicalPreventiveStrategyBasedDigitalToolImproveAccessDisruptorsExposurePrevention:Studyenvironmentalpractitionerseducation

Similar Articles

Cited By